Skip to content
Open access

Pharmacologic treatment strategies and association with major neonatal outcomes for patent ductus arteriosus in preterm infants

Jul 2026 · Frontiers in Pediatrics · Vol 14 · 0 citations · 31 references
Medicine

TL;DR

Gestational age showed the strongest association with the primary outcome of bronchopulmonary dysplasia and/or mortality and pharmacologic PDA treatment strategies were not independently associated with BPD and/or mortality in this retrospective cohort.

Abstract

Background Patent ductus arteriosus (PDA) is common in preterm infants. Although pharmacologic treatment promotes ductal closure, its impact on clinically meaningful outcomes remains uncertain. This study aimed to evaluate the association between different pharmacologic PDA treatment strategies and major neonatal outcomes. Methods This retrospective cohort study included preterm infants born at <32 weeks’ gestation who received pharmacologic treatment for clinically significant PDA following an integrated echocardiographic and clinical assessment in a tertiary-level neonatal intensive care unit between 2018 and 2024. Infants were categorized by treatment strategy (ibuprofen only, paracetamol only, or sequential therapy), treatment timing, and number of treatment courses. The primary outcome was a composite of bronchopulmonary dysplasia (BPD) and/or mortality. Secondary outcomes included intraventricular hemorrhage, necrotizing enterocolitis, retinopathy of prematurity, and sepsis. Results A total of 76 preterm infants were included, with a median gestational age of 28 weeks (IQR 26–30) and mean birth weight of 1,076 ± 343 g. Infants were treated with ibuprofen only (n = 31, 40.8%), paracetamol only (n = 27, 35.5%), or sequential therapy (n = 18, 23.7%). The composite outcome occurred in 39 infants (51.3%) and did not differ significantly across treatment groups. In multivariate analysis, gestational age emerged as the strongest independent predictor of BPD and/or mortality (adjusted OR 0.54, 95% CI 0.38–0.77; p = 0.001), while treatment category was not independently associated with outcomes. Conclusion Pharmacologic PDA treatment strategies were not independently associated with BPD and/or mortality in this retrospective cohort. Gestational age showed the strongest association with the primary outcome; however, residual confounding and limited statistical power preclude causal or equivalence conclusions.

Read PDF

Similar papers

The best treatment for the management of hemodynamically significant patent ductus arteriosus in preterm neonates : a network meta-analysis and risk-benefit analysis

Various pharmacological treatments are available for preterm infants with patent ductus arteriosus (PDA) but their risks and benefits are controversial. This study aimes to identify the best treatment of PDA using network meta-analysis (NMA) and risk-benefit assessment (RBA). Relevant randomized controlled trials (RCTs...

S. Eursiriwan · 0 citations
Sep 2026

Early Cardiopulmonary Physiology, Patent Ductus Arteriosus Characteristics, and Outcomes at the Limits of Viability.

OBJECTIVE To examine associations of center-specific, clinically assigned early clinical-hemodynamic patent ductus arteriosus (PDA) phenotypes and echocardiographic characteristics with in-hospital outcomes among infants born at 21-24 weeks' gestation. STUDY DESIGN Retrospective, single-center cohort of infants under...

A. R. Bischoff, Tiffany Lau, A. Stanford et al. · 0 citations
Open access Aug 2026

Clinical Predictors of Bronchopulmonary Dysplasia in Very Preterm Infants

Background: Bronchopulmonary dysplasia (BPD) remains one of the most common chronic respiratory complications among very preterm infants and is associated with significant neonatal morbidity, prolonged hospitalization, impaired neurodevelopment, and increased healthcare utilization. Improvements in neonatal intensive c...

Priyanka Bhagat, Smirity Murmoo, Ranju Mehta et al. · 0 citations
Review Oct 2026

Association of Early Low Superior Vena Cava Flow among Neonates Born Very Preterm and Outcomes: A Systematic Review and Meta-Analysis.

OBJECTIVE To review systematically and meta-analyze the association of low superior vena cava flow (SVCF), diagnosed on echocardiography within the first 48 hours after birth, with morbidity, such as intraventricular hemorrhage (IVH), and mortality among preterm neonates (<32 weeks gestational age [GA]). STUDY DESIGN...

Nishkal Persad, Dwayne Mascarenhas, C. Devion et al. · 0 citations
Open access Oct 2026

Association between prophylactic hydrocortisone and focal intestinal perforations in preterm infants born before 28 weeks gestation: an observational propensity matched population study in England and Wales.

OBJECTIVE To examine the association between prophylactic hydrocortisone, given to prevent bronchopulmonary dysplasia, and the risk of focal intestinal perforation (FIP) in preterm infants. DESIGN Retrospective cohort study using routinely-collected data from infants born between 2016 and 2023. SETTING All English...

Alice Aveline, A. Bottle, Anna Milan et al. · 0 citations
Open access Aug 2026

Burden and predictors of bronchopulmonary dysplasia in preterm infants: A seven-year cohort

Background Bronchopulmonary dysplasia (BPD) remains a significant complication of prematurity with substantial morbidity and variable incidence globally. Local data are essential for developing effective preventive strategies and improving outcomes. Objectives To estimate the incidence of BPD and temporal trend in a Sa...

M. Bamehrez, Ahlam A. Mazi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.